Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio

FARALLON CAPITAL MANAGEMENT LLC Performance:

2024 Q3: 9.31%YTD: 19.79%2023: 17.29%

Performance for 2024 Q3 is 9.31%, and YTD is 19.79%, and 2023 is 17.29%.

About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in SAN FRANCISCO, CA. On 20-Jul-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $41.2 Billions. In it's latest 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $20.4 Billions as of 30 Sep, 2024.

The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are IQV, EXEL, UNH. The fund has invested 3.7% of it's portfolio in IQVIA HLDGS INC and 3.2% of portfolio in EXELIXIS INC.

The fund managers got completely rid off ASTRAZENECA PLC, CEREVEL THERAPEUTICS HLDNG I (CERE) and CRISPR THERAPEUTICS AG (CRSP) stocks. They significantly reduced their stock positions in GERON CORP (GERN), INSMED INC (INSM) and UNITED THERAPEUTICS CORP DEL (UTHR). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in WOODWARD INC (WWD), SOUTHWESTERN ENERGY CO (SWN) and SQUARESPACE INC (SQSP). The fund showed a lot of confidence in some stocks as they added substantially to DYNE THERAPEUTICS INC (DYN), TRANSMEDICS GROUP INC (TMDX) and BIODESIX INC (BDSX).

FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that FARALLON CAPITAL MANAGEMENT LLC made a return of 9.31% in the last quarter. In trailing 12 months, it's portfolio return was 30.37%.

New Buys

Ticker	$ Bought
woodward inc	197,923,000
southwestern energy co	184,811,000
squarespace inc	134,258,000
ishares bitcoin trust etf	52,027,200
liberty broadband corp	51,011,400
healthcare rlty tr	47,244,400
bridgebio pharma inc	44,478,600
evolent health inc	18,070,900

New stocks bought by FARALLON CAPITAL MANAGEMENT LLC

Additions

Ticker	% Inc.
dyne therapeutics inc	7,033
transmedics group inc	2,100
biodesix inc	146
crinetics pharmaceuticals in	133
twist bioscience corp	77.42
new oriental ed & technology	72.4
disney walt co	62.74
biohaven ltd	62.04

Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC

Reductions

Ticker	% Reduced
geron corp	-99.74
insmed inc	-99.47
united therapeutics corp del	-99.3
cogent biosciences inc	-96.00
ultragenyx pharmaceutical in	-95.96
novavax inc	-95.76
roivant sciences ltd	-94.5
vaxcyte inc	-90.34

FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker	$ Sold
iqiyi inc	-162,081,000
astrazeneca plc	-187,934,000
cerevel therapeutics hldng i	-48,659,100
sep acquisition corp	-6,410
pg&e corp	-12,088,000
spyre therapeutics inc	-15,657,700
kensington capital acquisiti	-15,058
crispr therapeutics ag	-28,625,300

FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 39.7% of it's holdings in Healthcare sector.

Sector	%
Healthcare	39.7
Technology	14.8
Industrials	12.5
Financial Services	10
Communication Services	9.3
Others	6.6
Real Estate	2.7
Consumer Cyclical	1.9
Basic Materials	1.4
Energy	1.2

Market Cap. Distribution

FARALLON CAPITAL MANAGEMENT LLC has about 64.7% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
LARGE-CAP	44.7
MID-CAP	27.3
MEGA-CAP	20
UNALLOCATED	6.3
SMALL-CAP	1.4

Stocks belong to which Index?

About 67.7% of the stocks held by FARALLON CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
S&P 500	54.2
Others	32.3
RUSSELL 2000	13.5

Top 5 Winners (%)		%
FBRX	forte biosciences inc	880.7 %
RVMD	revolution medicines inc	96.4 %
AMLX	amylyx pharmaceuticals inc	70.5 %
CNTA	centessa pharmaceuticals plc	59.3 %
ACLX	arcellx inc	51.3 %

Top 5 Winners ($)		$
TRU	transunion	178.0 M
CBRE	cbre group inc	124.0 M
UNH	unitedhealth group inc	118.5 M
AON	aon plc	95.9 M
EXEL	exelixis inc	94.2 M

Top 5 Losers (%)		%
ELEV	elevation oncology inc	-77.6 %
IRWD	ironwood pharmaceuticals inc	-36.8 %
PGNY	progyny inc	-34.6 %
SAGE	sage therapeutics inc	-33.5 %
RGTI	rigetti computing inc	-33.3 %

Top 5 Losers ($)		$
SRPT	sarepta therapeutics inc	-79.1 M
ABNB	airbnb inc	-43.2 M
GOOG	alphabet inc	-29.2 M
INTU	intuit	-22.8 M
MSFT	microsoft corp	-18.8 M

FARALLON CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT LLC has 146 stocks in it's portfolio. About 29.7% of the portfolio is in top 10 stocks. SRPT proved to be the most loss making stock for the portfolio. TRU was the most profitable stock for FARALLON CAPITAL MANAGEMENT LLC last quarter.

Last Reported on: 14 Nov, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ABC	cencora inc	0.26	235,200	52,938,800	reduced	-3.13

ABNB	airbnb inc	1.47	2,371,200	300,692,000	added	39.4

ACLX	arcellx inc	0.00	4,000	334,040	unchanged	0.00

ADI	analog devices inc	1.66	1,472,100	338,833,000	added	14.58

AGIO	agios pharmaceuticals inc	1.23	5,660,870	251,512,000	added	0.11

AGLE	spyre therapeutics inc	0.00	0.00	0.00	sold off	-100

ALT	altimmune inc	0.00	27,600	169,464	unchanged	0.00

AMGN	amgen inc	0.07	47,000	15,143,900	reduced	-79.74

AMLX	amylyx pharmaceuticals inc	0.02	1,150,220	3,726,720	unchanged	0.00

ANAB	anaptysbio inc	0.03	183,876	6,159,850	new

AON	aon plc	2.89	1,706,000	590,259,000	reduced	-9.02

APLS	apellis pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ARDX	ardelyx inc	0.00	23,000	158,470	unchanged	0.00

ARMK	aramark	2.20	11,636,900	450,699,000	reduced	-31.26

ARQT	arcutis biotherapeutics inc	0.00	26,000	241,800	unchanged	0.00

ARYD	arya sciences acqu corp iv	0.00	0.00	0.00	sold off	-100

AXSM	axsome therapeutics inc	0.00	4,000	359,480	unchanged	0.00

BACA	berenson acquisition corp i	0.00	0.00	0.00	sold off	-100

BBIO	bridgebio pharma inc	0.22	1,747,000	44,478,600	new

BCSA	blockchain coinvstrs acq crp	0.00	150,000	3,000	unchanged	0.00